News Articles Tagged: Gastric Secretion
Exploring the Therapeutic Potential of Proglumide in Gastrointestinal Health
Delve into the historical and potential applications of Proglumide (CAS 6620-60-6) in managing gastrointestinal conditions, focusing on its CCK antagonism.
The Science Behind Proglumide: A Cholecystokinin Antagonist from NINGBO INNO PHARMCHEM CO.,LTD.
Delve into the scientific mechanisms of Proglumide powder, a CCK antagonist, with insights from NINGBO INNO PHARMCHEM CO.,LTD.
Navigating Ulcer Treatment: The Role of Proglumide Powder in Inhibiting Gastric Motility
Discover how Proglumide Powder (CAS 6620-60-6) aids in ulcer treatment by inhibiting gastric motility and reducing gastric secretions.